Virtus Fund Advisers, LLC Adma Biologics, Inc. Transaction History
Virtus Fund Advisers, LLC
- $26.8 Million
- Q4 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 3,021 shares of ADMA stock, worth $63,169. This represents 0.19% of its overall portfolio holdings.
Number of Shares
3,021
Previous 10,478
71.17%
Holding current value
$63,169
Previous $209,000
75.6%
% of portfolio
0.19%
Previous 1.03%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
343Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$390 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$381 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$311 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$236 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$116 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.11B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...